• 1
    Sumner AE, Cowie CC. Ethnic differences in the ability of triglyceride levels to identify insulin resistance. Atherosclerosis. 2008;196:696703.
  • 2
    Diabetes Atlas. Updated guidelines for the definition, diagnosis and classification of diabetes. International Diabetes Federation. 19th World Diabetes Congress, Cape Town, South Africa; 2006.
  • 3
    Yan W, Yang X, Zheng Y, et al. The metabolic syndrome in Uygur and Kazak population. Diabetes Care. 2005;28:25542555.
  • 4
    Wu HY, Chen LL, Zheng J, et al. Simple anthropometric indices in relation to cardiovascular risk factors in Chinese type 2 diabetic patients. Chin J Physiol. 2007;3:135142.
  • 5
    Li LL, Zhang YM, Du JY, et al. Analysis of metabolic features and food composition related with pathogenesis of type 2 diabetes mellitus in population of Uigurs and Kazaks in Xinjiang. Chin J Endocrinol Metab. 2005;21:141142.
  • 6
    Tao YC, Mao XM, Xie ZJ, et al. The prevalence of type 2 diabetes and hypertension in Uygur and Kazak populations. Cardiovasc Toxicol. 2008;8:155159.
  • 7
    Huxley R, James WP. Ethnic comparisons of the cross-sectional relationships between measures of body size with diabetes and hypertension. Obes Rev. 2008;1:5361.
  • 8
    Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365:14151428.
  • 9
    Sumner AE. Ethnic differences in triglyceride levels and high-density lipoprotein lead to underdiagnosis of the metabolic syndrome in black children and adults. J Pediatr. 2009;155:S7.e7e11.
  • 10
    Goodarzi MO, Guo X, Taylor KD, et al. Lipoprotein lipase is a gene for insulin resistance in Mexican Americans. Diabetes. 2004;53:214220.
  • 11
    Monzillo LU, Hamby O. Evaluation of insulin sensitivity in clinical practice and in research settings. Nutr Rev. 2003;61:397412.
  • 12
    Keogh JB, Clifton P. The effect of meal replacements high in glycomacropeptide on weight loss and markers of cardiovascular disease risk. Am J Clin Nutr. 2008;87:16021605.